Learn to generate MORE INCOME with LESS RISK

Moderna Inc (MRNA)

$119.86 +$1.61 (+1.36%)

Data as of last close (September 30, 2022)

Dividend

Ranking

Safety

Ranking

Value

Ranking

Momentum

Ranking

The Strike Zone

Strike Zone Factors

Option Snapshot

Next Dividend / EPS Dates

Next Ex Div Date (Est.)	Next EPS Date (Est.)
N/A	N/A

Stock Chart

Stock Summary
Last price (Close) $119.86
52-Week High (11/29/21) $376.65
52-Week Lo (9/29/22) $115.03
% Below 52-Week High -68.18%
Relative Strength Index (RSI) (14-day) 33.9
Market Cap. ($ Bil) $46.90
Avg. Daily Volume (30D) 4,841,154
Beta (5Y,all) 1.04
Historical Volatility (5Y,all) (%) 95.0%
Maximum Drawdown (5Y,all) (%) 75.8%
Pullback as % of Max. DD 89.9%

Sector/Industry
Healthcare
Biotechnology

Business Description
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine,… www.modernatx.com Read more Business Description Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. www.modernatx.com

Business Description

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine,…

www.modernatx.com Read more

Dividend Summary
Dividend Yield (%) 0.00%
Annual Payout (Fwd.) N/A
Next Ex-Div Amount (Est.) N/A
Dividend Growth (Yrs.)
Dividend Growth (1-year) (%)
Dividend CAGR (5-year) (%)
Dividend CAGR (10-year) (%)
Payout Ratio (Fwd.) (%) N/A
Payment Frequency N/A
Payment Months N/A

Total Return / Momentum
Period	Return	vs. Ind.	vs. S&P
1 Week	-4.36%	-7.63%	-1.45%
1 Month	-13.01%	-9.17%	-2.96%
3 Months	-17.22%	-28.60%	-11.94%
1 Year	-69.27%	-35.13%	-52.52%
5 Years	N/A	N/A	N/A

Valuation Summary
Multiple	Current	Forward	5yr Avg.
P/Sales	2.27x	4.69x	N/A
P/E	3.65x	16.76x	N/A
P/Book	2.61x	N/A	N/A
EV/EBITDA	2.40x	3.05x	N/A
Share. Yield %	6.01%

Annual Sales & EPS

LFQ Sales (12/31/2021) $17,736
LFQ EPS (12/31/2021) $28.29
Fwd Sales Est. (12/31/2022) $21,836
Fwd EPS Est. (12/31/2022) $26.26

Quarterly Sales & EPS

LFQ Sales (6/2022) $4,566
LFQ EPS (6/2022) $5.24
Fwd Sales Est. (9/2022) $4,506
Fwd EPS Est. (9/2022) $4.50

Yahoo Finance News
Mirati (MRTX) Down 16.1% Since Last Earnings Report: Can It Rebound? March 30, 2023 Mirati (MRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. 1 Growth Stock With 741% Upside, According to Wall Street March 30, 2023 Shares of biotech Novavax (NASDAQ: NVAX) have plunged 91% in the past year as the company has struggled to make its mark in the coronavirus vaccine market. Novavax's lack of success in this space is even more troubling, considering global COVID-19 vaccine sales will drop substantially starting this year, so even the leaders in the […] Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility March 30, 2023 Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and the Government of the Republic of Kenya have finalized an agreement to establish an mRNA manufacturing facility in the Republic of Kenya. Moderna (MRNA) Gains But Lags Market: What You Should Know March 29, 2023 Moderna (MRNA) closed at $148.80 in the latest trading session, marking a +1.28% move from the prior day. J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out March 29, 2023 Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. Is Moderna Stock A Sell As Senators Eye 400% Price Hike For Covid Shots? March 29, 2023 Moderna stock is under pressure as the company contends with a pitfall in Covid shots and plans for a 400% price hike. Is MRNA stock a sell? What WHO’s New Covid-19 Vaccine Guidance Means for Pfizer and Moderna Stock March 29, 2023 The two companies have said they expect roughly 100 million Covid-19 vaccines doses to be administered in the U.S. this year. Why Is Denali Therapeutics Inc. (DNLI) Down 16% Since Last Earnings Report? March 29, 2023 Denali Therapeutics Inc. (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Moderna's CEO Just Gave Investors a Huge Reason to Sell the Stock March 29, 2023 Recently, Moderna (NASDAQ: MRNA)'s CEO highlighted a big risk for the company: Demand for its COVID-19 vaccine is going to crater. It's a big enough decline to get investors worried. Moderna is anticipating a big drop in demand this year as concerns around COVID-19 subside. The Ultimate Growth Stock to Buy With $150 Right Now March 29, 2023 What makes a top growth stock? It's generated billions of dollars thanks to its coronavirus vaccine -- but the company has other major growth drivers on the way. Let's find out more about this ultimate growth stock to buy now.

Yahoo Finance News

Mirati (MRTX) Down 16.1% Since Last Earnings Report: Can It Rebound? March 30, 2023
Mirati (MRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
1 Growth Stock With 741% Upside, According to Wall Street March 30, 2023
Shares of biotech Novavax (NASDAQ: NVAX) have plunged 91% in the past year as the company has struggled to make its mark in the coronavirus vaccine market. Novavax's lack of success in this space is even more troubling, considering global COVID-19 vaccine sales will drop substantially starting this year, so even the leaders in the […]
Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility March 30, 2023
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and the Government of the Republic of Kenya have finalized an agreement to establish an mRNA manufacturing facility in the Republic of Kenya.
Moderna (MRNA) Gains But Lags Market: What You Should Know March 29, 2023
Moderna (MRNA) closed at $148.80 in the latest trading session, marking a +1.28% move from the prior day.
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out March 29, 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.
Is Moderna Stock A Sell As Senators Eye 400% Price Hike For Covid Shots? March 29, 2023
Moderna stock is under pressure as the company contends with a pitfall in Covid shots and plans for a 400% price hike. Is MRNA stock a sell?
What WHO’s New Covid-19 Vaccine Guidance Means for Pfizer and Moderna Stock March 29, 2023
The two companies have said they expect roughly 100 million Covid-19 vaccines doses to be administered in the U.S. this year.
Why Is Denali Therapeutics Inc. (DNLI) Down 16% Since Last Earnings Report? March 29, 2023
Denali Therapeutics Inc. (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Moderna's CEO Just Gave Investors a Huge Reason to Sell the Stock March 29, 2023
Recently, Moderna (NASDAQ: MRNA)'s CEO highlighted a big risk for the company: Demand for its COVID-19 vaccine is going to crater. It's a big enough decline to get investors worried. Moderna is anticipating a big drop in demand this year as concerns around COVID-19 subside.
The Ultimate Growth Stock to Buy With $150 Right Now March 29, 2023
What makes a top growth stock? It's generated billions of dollars thanks to its coronavirus vaccine -- but the company has other major growth drivers on the way. Let's find out more about this ultimate growth stock to buy now.

Stock Twits

Moderna Inc (MRNA)

Sign Up to Unlock Features

Moderna Inc (MRNA)

Dividend

Safety

Value

Momentum